Will India Get Monoclonal Antibodies After Serum India's Agreement With Merck?
PUBLISHED ON: October 23, 2020 | Duration: 20 min, 30 sec
Donald Trump called monoclonal antibodies the 'cure' as he recovered from Covid after being administered a cocktail of them. Now Serum India has signed a deal with pharmaceutical company Merck and a non-profit organisation to ensure this expensive treatment is accessible globally, even in low income countries. Does that mean it will be available in India in the future?